R01 CA235667/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2019	4
2020	7
2021	9
2022	9
2023	10
2024	2

1

Quantifying Interrater Agreement and Reliability Between Thoracic Pathologists: Paradoxical Behavior of Cohen's Kappa in the Presence of a High Prevalence of the Histopathologic Feature in Lung Cancer.

Tan KS, Yeh YC, Adusumilli PS, Travis WD. Tan KS, et al. JTO Clin Res Rep. 2023 Dec 16;5(1):100618. doi: 10.1016/j.jtocrr.2023.100618. eCollection 2024 Jan. JTO Clin Res Rep. 2023. PMID: 38283651 Free PMC article.

2

Ex vivo pleural effusion cultures to study chimeric antigen receptor T cell cytotoxicity in an immunocompetent environment.

Tano ZE, Kiesgen S, Chintala NK, Dozier J, Quach HT, Messinger J, Tan KS, Adusumilli PS. Tano ZE, et al. Cell Rep Methods. 2023 Nov 20;3(11):100622. doi: 10.1016/j.crmeth.2023.100622. Epub 2023 Oct 23. Cell Rep Methods. 2023. PMID: 37875122 Free PMC article.

3

Management of Pericardial Effusion in Patients With Solid Tumor: An Algorithmic, Multidisciplinary Approach Results in Reduced Mortality After Paradoxical Hemodynamic Instability.

Choe JK, Byun AJ, Robinson E, Drake L, Tan KS, McAleer EP, Schaffer WL, Liu JE, Chen LL, Buchholz T, Yohannes-Tomicich J, Yarmohammadi H, Ziv E, Solomon SB, Huang J, Park BJ, Jones DR, Adusumilli PS. Choe JK, et al. Ann Surg. 2024 Jan 1;279(1):147-153. doi: 10.1097/SLA.0000000000006114. Epub 2023 Oct 6. Ann Surg. 2024. PMID: 37800338

4

Tumor-Targeted Nonablative Radiation Promotes Solid Tumor CAR T-cell Therapy Efficacy.

Quach HT, Skovgard MS, Villena-Vargas J, Bellis RY, Chintala NK, Amador-Molina A, Bai Y, Banerjee S, Saini J, Xiong Y, Vista WR, Byun AJ, De Biasi A, Zeltsman M, Mayor M, Morello A, Mittal V, Gomez DR, Rimner A, Jones DR, Adusumilli PS. Quach HT, et al. Cancer Immunol Res. 2023 Oct 4;11(10):1314-1331. doi: 10.1158/2326-6066.CIR-22-0840. Cancer Immunol Res. 2023. PMID: 37540803 Free PMC article.

5

Organ-specific heterogeneity in tumor-infiltrating immune cells and cancer antigen expression in primary and autologous metastatic lung adenocarcinoma.

Restle D, Dux J, Li X, Byun AJ, Choe JK, Li Y, Vaghjiani RG, Thomas C, Misawa K, Tan KS, Jones DR, Chintala NK, Adusumilli PS. Restle D, et al. J Immunother Cancer. 2023 Jun;11(6):e006609. doi: 10.1136/jitc-2022-006609. J Immunother Cancer. 2023. PMID: 37349126 Free PMC article.

6

Response to Letter to the Editor: "Which Percentage of Micropapillary and Solid Histological Patterns in Lymph Node Metastases Is Significantly Associated With Poor Outcomes?".

Choe JK, Li Y, Adusumilli PS. Choe JK, et al. J Thorac Oncol. 2023 Jul;18(7):e76-e77. doi: 10.1016/j.jtho.2023.04.017. J Thorac Oncol. 2023. PMID: 37348999 No abstract available.

7

c-Kit signaling potentiates CAR T cell efficacy in solid tumors by CD28- and IL-2-independent co-stimulation.

Xiong Y, Taleb M, Misawa K, Hou Z, Banerjee S, Amador-Molina A, Jones DR, Chintala NK, Adusumilli PS. Xiong Y, et al. Nat Cancer. 2023 Jul;4(7):1001-1015. doi: 10.1038/s43018-023-00573-4. Epub 2023 Jun 19. Nat Cancer. 2023. PMID: 37336986

8

A Prospective Clinical Trial to Evaluate Mesothelin as a Biomarker for the Clinical Management of Patients With Esophageal Adenocarcinoma.

Byun AJ, Grosser RA, Choe JK, Rizk NP, Tang LH, Molena D, Tan KS, Restle D, Cheema W, Zhu A, Gerdes H, Markowitz AJ, Bains MS, Rusch VW, Jones DR, Adusumilli PS. Byun AJ, et al. Ann Surg. 2023 Nov 1;278(5):e1003-e1010. doi: 10.1097/SLA.0000000000005885. Epub 2023 Apr 27. Ann Surg. 2023. PMID: 37185875

9

Micropapillary and Solid Histologic Patterns in N1 and N2 Lymph Node Metastases Are Independent Factors of Poor Prognosis in Patients With Stages II to III Lung Adenocarcinoma.

Li Y, Byun AJ, Choe JK, Lu S, Restle D, Eguchi T, Tan KS, Saini J, Huang J, Rocco G, Jones DR, Travis WD, Adusumilli PS. Li Y, et al. J Thorac Oncol. 2023 May;18(5):608-619. doi: 10.1016/j.jtho.2023.01.002. Epub 2023 Jan 18. J Thorac Oncol. 2023. PMID: 36681298 Free PMC article.

10

Replication competent retrovirus testing (RCR) in the National Gene Vector Biorepository: No evidence of RCR in 1,595 post-treatment peripheral blood samples obtained from 60 clinical trials.

Cornetta K, Yao J, House K, Duffy L, Adusumilli PS, Beyer R, Booth C, Brenner M, Curran K, Grilley B, Heslop H, Hinrichs CS, Kaplan RN, Kiem HP, Kochenderfer J, Kohn DB, Mailankody S, Norberg SM, O'Cearbhaill RE, Pappas J, Park J, Ramos C, Ribas A, Rivière I, Rosenberg SA, Sauter C, Shah NN, Slovin SF, Thrasher A, Williams DA, Lin TY. Cornetta K, et al. Mol Ther. 2023 Mar 1;31(3):801-809. doi: 10.1016/j.ymthe.2022.12.006. Epub 2022 Dec 14. Mol Ther. 2023. PMID: 36518078 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

34 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year